ABSTRACT CONTENT
- Abstracts on research obviously not yet performed and results not yet obtained will be rejected.
- Case studies will not be considered (unless if first-in-human).
- Systematic reviews are accepted but literature reviews are not.
- Papers already presented at another meeting will not be considered, unless the previous audience is distinct from the ESTRO meets Asia 2026 congress audience (e.g. national meetings).
- Abstracts should include new information and not solely include materials already published.
- If very similar abstracts are submitted by the same authors, the Scientific Programme Committee reserves the right to select only one of the abstracts and reject any others.
ABSTRACT TOPICS
- Advanced delivery techniques, SBRT
This category includes abstracts on methods and application of techniques such as for example spatially fractionated radiotherapy, SBRT
- Algorithms and applications for treatment planning (photon, electron, proton)
This category includes studies related to radiotherapy treatment planning for photon and particle therapy, including IMRT, VMAT, tomotherapy and others, including comparison studies and applications in general
Abstracts in this category may contain development and application of AI for tasks in radiotherapy, for example auto-segmentation, treatment planning, classification, workflow optimisation
This category includes technical and clinical studies involving brachytherapy
This category includes abstracts on clinical treatment and/or outcomes for breast cancers
This category includes abstracts on clinical treatment and/or outcomes for CNS malignancies
- Detectors, dose measurement and phantoms
Abstracts submitted to this category may contain classical experimental studies on characterisation of new detectors, phantom development, dose measurement and measurement protocols including radiation protection
- Education in radiation oncology
This category includes abstracts on radiation oncology education
- Gynaecological malignancies
This category includes abstracts on clinical treatment and/or outcomes for gynaecological malignancies
This category includes abstracts on clinical treatment and/or outcomes for haematological cancers
This category includes abstracts on clinical treatment and/or outcomes for head & neck cancers
- Health economics & health services research
This category includes abstracts on global health, health services research and economics
- Image acquisition and processing, imaging biomarkers
This category is aimed at abstracts describing studies related to development and validation of (novel) image acquisition and analysis strategies including CT, MRI, PET and potentially other imaging techniques used for radiotherapy planning, prescription, adaptation and outcome prediction
- Lower gastro-intestinal malignancies
This category includes abstracts on clinical treatment and/or outcomes for lower gastro-intestinal malignancies
This category includes abstracts on clinical treatment and/or outcomes for lung cancers
This category includes abstracts on mixed sites and palliative treatments
- MRI- and CBCT guided adaptive radiotherapy
This topic invites abstracts related to adaptive radiotherapy with either MRI or CBCT guidance, with a focus on offline, daily inter-fraction adaptation or intra-fraction motion management. Development and implementation of new adaptation strategies including patient validation can also be submitted
This category includes abstracts on clinical treatment and/or outcomes for paediatric tumours
- Patient care, preparation, immobilisation and IGRT verification protocols
This category includes abstracts on patient care, preparation, immobilisation and IGRT verification protocols
- Patient experience and quality of life
This category includes abstracts on patient experience and quality of life
This category includes technical and clinical studies involving proton or particle therapy
- Quality assurance and auditing
Abstracts submitted under this topic may report on quality assurance and auditing with a focus on physics and technology or application in clinical protocols and trials
- Radiobiology and biomarkers
Abstracts submitted under this topic may report on radiobiology and pre-clinical biomarkers
- RTT education, training, advanced practice and role developments
This category includes abstracts on RTT education, training, advanced practice and role developments
- RTT service evaluation, quality assurance and risk management
This category includes abstracts on RTT service evaluation, quality assurance and risk management
- RTT treatment planning, OAR and target definitions
This category includes abstracts on RTT treatment planning, OAR and target definitions
- Sarcoma/skin cancer/malignant melanoma
This category includes abstracts on clinical treatment and/or outcomes for sarcoma, skin cancer and malignant melanoma
- Upper gastro-intestinal malignancies
This category includes abstracts on clinical treatment and/or outcomes for upper gastro-intestinal malignancies
This category includes abstracts on clinical treatment and/or outcomes for urological cancers
This category includes abstracts of relevance for radiation oncology not related to any other category)